|
|
Article: Teva and Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen[R] Lo Litigation.
- Article from:
- Business Wire
- Article date:
- July 24, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has entered into a definitive agreement with Ortho-McNeil-Janssen to settle the patent infringement lawsuit in the U.S. District Court for the District of New Jersey related to Teva's generic version of the oral contraceptive, Ortho Tri-Cyclen[R] Lo. Under the terms of the settlement, Teva will obtain a release for past sales of its generic product, in exchange for an undisclosed royalty payment. Teva also will obtain a license to re-enter the market on December 31, 2015, or earlier in certain circumstances. The settlement will not become effective until the court enters a proposed ...
Related newspaper, magazine, and journal articles:
|
|
Article: Report Shows Popular Birth Control Pill, ORTHO ...
PR Newswire;
May 9, 2006 ;
700+ words
... ... The popular birth control pill, ORTHO TRI-CYCLEN(R) LO (norgestimate/ethinyl ... risk of pregnancy in heavier women using ORTHO TRI-CYCLEN LO. "A significant number ... Urology. "These results reinforce ORTHO TRI-CYCLEN LO as an effective birth control ...
|
|